Comparison of three radiopharmaceuticals for lung ventilation imaging

dc.contributor.authorEvbuomwan, Osayande
dc.date.accessioned2019-05-13T11:20:51Z
dc.date.available2019-05-13T11:20:51Z
dc.date.issued2018
dc.description.abstractA variety of radioacrosols have been tested in the past for lung ventilation scintigraphy in the assessment of pulmonary thromboembolism, Amongst these are the bone scan agent technetium 99m C"' re) methylene diphosphonate CMDP) and the myocardial perfusion agent methoxy isobutyl isonitrile (MIBI). However, diethylenetriaminepentaacetic acid (DTPA) currently remains the most commonly utilized The aim of this study was to compare the image quality and alveolar clearance Of MDP, DTPA and MlBl as ventilating agents in patients being investigated for pulmonary thromboembolisrn. Patients referred to our institution from August 2015 to July 2017 fora ventilation perfusion ( VQ) scan, who fulfilled the inclusion criteria were enrolled into the study as participants. Each ventilation agent was used to ventilate 43 panicipants, making a total Of 129 participants in the Study. Images wcrc assessed for quality and alveolar Clearance qualitatively and semi quantitatively respectively by a nuclear medicine physician blinded to the agent used. MIRI had superior image quality and slower alveolar clearance, with statistically very significant different results when compared to DTPA.
dc.description.librarianMT 2019en_ZA
dc.identifier.urihttps://hdl.handle.net/10539/26873
dc.language.isoenen_ZA
dc.subjectLung Ventilation
dc.subject.meshPulmonary Embolism
dc.titleComparison of three radiopharmaceuticals for lung ventilation imagingen_ZA
dc.typeThesisen_ZA
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Dr Osayande Evbuonwam.pdf
Size:
868.25 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Collections